Welcome to LookChem.com Sign In|Join Free
  • or
4-(methylamino)-1-phenylbutan-1-ol, also known as 4-MAPB, is a synthetic psychoactive substance belonging to the phenethylamine class. It is structurally similar to 3,4-methylenedioxyphenethylamine (MDPEA) and 3,4-methylenedioxyamphetamine (MDA), and is known for its stimulant and entactogenic effects. 4-MAPB has been reported to produce a range of psychological and physiological effects, including increased energy, euphoria, and altered perceptions. It is typically found in a powder form and is consumed orally or insufflated. Due to its psychoactive properties, 4-MAPB is subject to legal restrictions and is considered a controlled substance in many countries. It is important to note that the use of 4-MAPB can carry potential health risks and is not approved for medical use.

4266-01-7

Post Buying Request

4266-01-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4266-01-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4266-01-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,2,6 and 6 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 4266-01:
(6*4)+(5*2)+(4*6)+(3*6)+(2*0)+(1*1)=77
77 % 10 = 7
So 4266-01-7 is a valid CAS Registry Number.

4266-01-7Relevant academic research and scientific papers

Diaryldiamines with dual inhibition of the histamine H3 receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1- phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in pain

Altenbach, Robert J.,Black, Lawrence A.,Strakhova, Marina I.,Manelli, Arlene M.,Carr, Tracy L.,Marsh, Kennan C.,Wetter, Jill M.,Wensink, Erica J.,Hsieh, Gin C.,Honore, Prisca,Garrison, Tiffany Runyan,Brioni, Jorge D.,Cowart, Marlon D.

supporting information; experimental part, p. 7869 - 7873 (2011/01/12)

A series of compounds was designed as dual inhibitors of the H3 receptor and the norepinephrine transporter. Compound 5 (rNET Ki = 14 nM; rH3R Ki = 37 nM) was found to be efficacious in a rat model of osteoarthritic pain.

NOVEL CENTRAL-NERVOUS SYSTEM ACTING COMPOUNDS AND METHODS FOR THE TREATMENT OF CNS DISORDERS

-

Page/Page column 30, (2010/11/28)

This application relates to a new class of butylamine compounds useful as balanced serotonin/dopamine uptake inhibitors for treating a disease or condition for which inhibition of both serotonin and dopamine reuptake is beneficial, for example, depression

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4266-01-7